Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 379

DECLARATION re #377 MOTION to Preclude Further Interference with Third-Party Discovery and Compel Production of Documents And Deposition Testimony, or in the Alternative, Motion to Strike Defendants? Defense Under 35 U.S.C. Section 271(e)(1), #378 Memorandum in Support of Motion, OF MARIO MOORE by Amgen Inc.. (Attachments: #1 Confidential Exhibit Coversheet#2 Exhibit 1#3 Exhibit 2#4 Exhibit 3# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7# 8 Exhibit 8# 9 Exhibit 9, Part 1 of 2# 10 Exhibit 9, Part 2 of 2# 11 Exhibit 10# 12 Exhibit 11# 13 Exhibit 12# 14 Exhibit 15# 15 Exhibit 16# 16 Exhibit 17# 17 Exhibit 18#18 Exhibit 19#19 Exhibit 20#20 Exhibit 21#21 Exhibit 22#22 Exhibit 25#23 Exhibit 26#24 Exhibit 27# 25 Exhibit 28# 26 Exhibit 29#27 Exhibit 30)(Gottfried, Michael) Additional attachment(s) added on 4/16/2007 (Paine, Matthew). Additional attachment(s) added on 4/16/2007 (Paine, Matthew).

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 379 Att. 19 Case 1:05-cv-12237-WGY Document 379-20 Filed 04/13/2007 Page 1 of 4 EXHIBIT 20 Dockets.Justia.com Capm Mar-28-07 10 :14se 1:05-cv-12237-WGY From-KAYE SCHOLER LLP TP .02 3 Document 379-20 026823580 04/13/2007758 Page/02 of F4943 2 Filed KAYE S C H o L E R L_L_P Davia t- . Co s,noau 202 682-317 Fax 202 414-0344 dcousineaugkdyescholer .com The WPherxon Building 901 Fifteenth Street, NW Sure 1 100 Wasnington ' DC 20005 202 682-300 Fax 202 682-3580 www .kayescholer.com March 28, 2007 VIA E-MAIL AND FACSTMILE Deborah Fishman Day Casebeer Madrid & Batchelder LLP 20300 Stevens Creek Blvd ., Suite 400 Cupertino, CA 95014 Re : Amgen Irtc_ V . F. Hoffman- . a Roche Ltd . et al. 05-CV 12237 WGY (D . Mass) Dear DeborahI write regarding Amgen's blatant attempt to circumvent the court 1' s December 29, 2006, January 22, 2007, and March 2, 2007, orders regarding the scope of discovery . The court ruled three times that information regarding post-April 16, 2006 clinical trials is irrelevant to this lawsuit, beyond the scope of discovery, and would be unduly prejudicial and potentially disruptive to the ongoing discussions and negotiations between Roche and the FDA . This is true whether Amgen seeks the information through Roche or through unwitting third-parties_ Roche will not disregard the court's orders nor waive DaVita's confidentiality obligations . In short, Roche will not provide the requisite approval for DaVita to produce the information discussed in your letter of today to me. Similarly, Roche will not disregard the court's orders nor waive DaVita's confidentiality obligations at Monday's DaVita deposition . I was amazed to learn that orae week after the third and final order on this issue, you subpoenaed DaVita (but did not serve Roche), seeking "DaVita's actual or planned participation in any trial, research, or other study sponsored or conducted by or on behalf of ROCHI", scheduled to commence after April 18, 2006 ." (emphasis added) . Such information is clearly beyond the scope of the court's orders and Roche will oppose any effort by Amgen to elicit testimony on this subject. 131191ť "ID NEW YORK CnICpoo t-05 ANCELF-S WA5HINOTŠN, D C WEST PALM 15F^Cn FRAWKFURT LONRON SMANGnNi C :14 e Mar-28-07 10 aspm 1:05-cv-12237-WGY From-KAYE SCHOLER LLP Document 379-20 2026823580 04/13/2007 -758Page33 3of 4 -943 Filed T P .0 /0 F KAYE SCHOL.ERw-p Deborah Fishman 2 March 28, 2007 Please feel free to contact me if you have any questions. Sincerely, David L. Cousineau cc : Christian T . Kemnitz (via e-mail only) 131191ss wYA NEw YORK CNICAGO Z-05 ANGF-LP-s WASnINGTON . D .C . WFEST PALM SEAcm FRANKFu RT I-ONDON SMANGMA{ Mar-28-07 10 a4pe 1:05-cv-12237-WGY C :1s m From-KAYE SCHOLER LLP Document 379-20 20268Filed 04/13/2007-758 Page 103of 4-943 23580 T P .01 4 F KAYE SGHOLERup From : David l_. Cc 202 682-3 Fax 202 41 dcousineat The McPners 901 Fifteent Washingion, 202 682-3S Fax 202 682 WWW ' kayescl Lneau 7 0344 cayescholer .cam in Building Stree[, NW DC 20005 0 3580 oier_com FAX DATE, March 28, 2007 DELIVER TO: PRIMARY FAX NUMBER: Total number of pages incl this cover sheet : 3 NUMBER: 408-342-4587 Deborah Fishman 408-873-0220 If primary fax ntunbcr is unreachable, contact the addressee's telephone number for 4:ITM to fax number? YIN T1 IF YOU DO NOT RECEIVE ALL THE PAGES INDICAFTED ABOVE, PLEASE CALL US BACK AS SOON AS POSSIBLE AT :'' (202) 682-3617 NOTE: 'Foil faeaimile tranamiaoiuO contains confidentiat and/or legally privttege4 information from Fhc law firm Ki<yc seaolvr LLP intc1l4cd only for the u I e of the in44vi4ual(l) named on Ioc tronamiaaion sheet . If yuu arc nut Thr iarco4cd recipient, you are hereby notified that any amcloayrc, copying, d,atribution orthe IaIdol ; of any action in relianee',on the conzents of this facaimtic tranbmiaason is arrictly pronibitcd . If yya have rcceived this trans mission in error, plcaae nozify ua oy telepnonr immcaiar ly ao that we can arrange for the return of The docnmon" to ua av no coat to you. L.lacr H . 1038 ChanL/Mntrcr ti' 34484/4 Nw YORK CMICAGO L-05 ANGEL-. S WASMINCTON . Q .C . We5T PALM REACrt FR~.nKFuRT LONpGn SMANGMAI

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?